Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Association of the serum uric acid-to-HDL cholesterol ratio with insulin resistance and hyperandrogenemia in women with polycystic ovary syndrome: a retrospective cross-sectional study

4 affiliations
  1. 1Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University
  2. 2Department of Endocrinology, No. 971 Hospital of Navy
  3. 3Department of Endocrinology, The Affiliated Hospital of Qingdao University
  4. 4Department of Gynecology, The Affiliated Qingdao Third People’s Hospital of Qingdao University

Abstract

Background: Polycystic ovary syndrome (PCOS) is commonly accompanied by insulin resistance (IR) and hyperandrogenemia. The serum uric acid to high-density lipoprotein cholesterol ratio (UHR) is an emerging composite metabolic biomarker, yet its relationship with metabolic disturbances in PCOS remains unclear.

Objective: To evaluate the associations of UHR with IR and hyperandrogenemia in women with PCOS and compare its discrimination with the triglyceride-glucose (TyG) index.

Methods: This single-center retrospective cross-sectional study included 349 hospitalized women aged 18–45 years with PCOS (2003 Rotterdam criteria, 2012–2025). UHR was calculated as [UA (mg/dL)/HDL-C (mg/dL)]×100%. Associations with IR (HOMA-IR ≥2.69) and hyperandrogenemia were examined using correlation analyses, multivariable logistic models adjusted for age, body mass index, and glomerular filtration rate, and receiver operating characteristic analyses with bootstrap internal validation.

Results: Higher UHR quartiles were associated with progressively worse metabolic profiles (P for trend <0.05). UHR correlated positively with HOMA-IR (rs=0.449; partial r=0.201 adjusted for age and BMI, both P<0.001). Each 1-SD UHR increase was associated with higher odds of IR after full adjustment (OR = 1.80, 95%CI 1.22~2.66; Q4 vs Q1: OR = 4.12, 95%CI 1.75~9.69). The exploratory hyperandrogenemia analysis showed increased odds in the highest versus lowest quartile in the fully adjusted model (Firth OR = 5.45, 95%CI 1.21~24.53), but no significant association for continuous UHR (OR = 1.29 per 1-SD, 95%CI 0.89~1.87). The AUC of UHR for IR (0.749) was numerically higher than the TyG index (0.691; P = 0.092) and similar to serum UA (0.739); the UHR+TyG combination yielded 0.772 (optimism-corrected 0.769), a small increment over UHR alone.

Conclusions: Elevated UHR is independently associated with IR and greater metabolic severity in women with PCOS, with discriminative performance not statistically different from the TyG index and a small increment over a basic clinical model. UHR is a simple, inexpensive auxiliary indicator for assessing metabolic severity in PCOS; its clinical utility requires prospective validation.

Related

  1. High Cholesterol Facilitates Ovarian Androgen Production and Contributes to the Development of Polycystic Ovary Syndrome
    Yue Liu, Shourui Hu, Xiaofan Liang +4
    PhenomicsPeer-reviewedLicence not statedFull textObstetrics, gynaecology & paediatricsPMC
  2. Association Between Triglyceride-glucose Index, Neutrophil to High-density Lipoprotein Cholesterol Ratio and Atrial Fibrillation: A Retrospective Study in China.
    Kai Huang, Wang-Jun Hou, Ming-Qi Tong +3
    Journal of epidemiology and global healthPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMCPMC
  3. Age-specific association between remnant cholesterol and insulin resistance in women with polyendocrine metabolic ovarian syndrome
    Chiyuan Yu, Zhonghua Sun, Qinyao Wu +3
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  4. Nonlinear association of cholesterol, high-density lipoprotein, and glucose index with the risk of prediabetes and diabetes in normal-weight middle-aged and older Chinese adults: a multicenter retrospective cohort study
    Junling Ding, Zhimao Cai, Xianglin Wang +2
    Frontiers in nutritionPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMCEurope PMC
  5. Association between preoperative monocyte-to-HDL cholesterol ratio and postoperative atrial fibrillation after esophagectomy for ESCC: a propensity score-matched retrospective cohort study
    Zhengwei Zhang, Haiyan Liu, Bo Xia +4
    Journal of Cardiothoracic SurgeryPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
BibTeX
@article{li2026association,
  title = {{Association of the serum uric acid-to-HDL cholesterol ratio with insulin resistance and hyperandrogenemia in women with polycystic ovary syndrome: a retrospective cross-sectional study}},
  author = {Xinde Li and Yuwei He and Yanhong Liu and Zhen Liu and Fei Yan and Xuefeng Wang and Can Wang and Lin Han and Ying Chen and Lingling Cui and Yuchun Li},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = nov,
  doi = {10.3389/fendo.2026.2008740},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.2008740/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Association of the serum uric acid-to-HDL cholesterol ratio with insulin resistance and hyperandrogenemia in women with polycystic ovary syndrome: a retrospective cross-sectional study
AU  - Xinde Li
AU  - Yuwei He
AU  - Yanhong Liu
AU  - Zhen Liu
AU  - Fei Yan
AU  - Xuefeng Wang
AU  - Can Wang
AU  - Lin Han
AU  - Ying Chen
AU  - Lingling Cui
AU  - Yuchun Li
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.2008740
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.2008740/full
AB  - Background: Polycystic ovary syndrome (PCOS) is commonly accompanied by insulin resistance (IR) and hyperandrogenemia. The serum uric acid to high-density lipoprotein cholesterol ratio (UHR) is an emerging composite metabolic biomarker, yet its relationship with metabolic disturbances in PCOS remains unclear.  Objective: To evaluate the associations of UHR with IR and hyperandrogenemia in women with PCOS and compare its discrimination with the triglyceride-glucose (TyG) index.  Methods: This single-center retrospective cross-sectional study included 349 hospitalized women aged 18–45 years with PCOS (2003 Rotterdam criteria, 2012–2025). UHR was calculated as [UA (mg/dL)/HDL-C (mg/dL)]×100%. Associations with IR (HOMA-IR ≥2.69) and hyperandrogenemia were examined using correlation analyses, multivariable logistic models adjusted for age, body mass index, and glomerular filtration rate, and receiver operating characteristic analyses with bootstrap internal validation.  Results: Higher UHR quartiles were associated with progressively worse metabolic profiles (P for trend <0.05). UHR correlated positively with HOMA-IR (rs=0.449; partial r=0.201 adjusted for age and BMI, both P<0.001). Each 1-SD UHR increase was associated with higher odds of IR after full adjustment (OR = 1.80, 95%CI 1.22~2.66; Q4 vs Q1: OR = 4.12, 95%CI 1.75~9.69). The exploratory hyperandrogenemia analysis showed increased odds in the highest versus lowest quartile in the fully adjusted model (Firth OR = 5.45, 95%CI 1.21~24.53), but no significant association for continuous UHR (OR = 1.29 per 1-SD, 95%CI 0.89~1.87). The AUC of UHR for IR (0.749) was numerically higher than the TyG index (0.691; P = 0.092) and similar to serum UA (0.739); the UHR+TyG combination yielded 0.772 (optimism-corrected 0.769), a small increment over UHR alone.  Conclusions: Elevated UHR is independently associated with IR and greater metabolic severity in women with PCOS, with discriminative performance not statistically different from the TyG index and a small increment over a basic clinical model. UHR is a simple, inexpensive auxiliary indicator for assessing metabolic severity in PCOS; its clinical utility requires prospective validation.
SN  - 1664-2392
ER  -